1. Home
  2. SHBI vs REPL Comparison

SHBI vs REPL Comparison

Compare SHBI & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

HOLD

Current Price

$19.19

Market Cap

636.2M

Sector

Finance

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$2.46

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHBI
REPL
Founded
1876
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
636.2M
692.8M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
SHBI
REPL
Price
$19.19
$2.46
Analyst Decision
Buy
Hold
Analyst Count
3
9
Target Price
$19.17
$5.67
AVG Volume (30 Days)
228.2K
9.8M
Earning Date
04-23-2026
05-21-2026
Dividend Yield
2.45%
N/A
EPS Growth
34.85
5.25
EPS
1.78
N/A
Revenue
$20,853,000.00
N/A
Revenue This Year
$8.97
N/A
Revenue Next Year
$6.26
N/A
P/E Ratio
$10.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.67
$1.50
52 Week High
$20.68
$13.24

Technical Indicators

Market Signals
Indicator
SHBI
REPL
Relative Strength Index (RSI) 51.13 33.62
Support Level $18.88 $1.50
Resistance Level $19.31 $8.83
Average True Range (ATR) 0.50 0.45
MACD -0.04 0.04
Stochastic Oscillator 21.00 18.35

Price Performance

Historical Comparison
SHBI
REPL

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: